Neurology News

Introducing electroconvulsive therapy earlier in a treatment course for major depressive disorder or bipolar disorder may lead to improvements in clinical outcomes, according to a study published in the Journal of Clinical Psychiatry.

Aptinyx Inc. announced it has completed enrollment in the company’s ongoing phase 2 study of NYX-458, an oral treatment for cognitive impairment associated with Parkinson’s disease and dementia with Lewy bodies.

Mortality rates were significantly higher among veterans with drug-resistant epilepsy compared with other veterans and the general United States population, researchers reported in JAMA Neurology.

Alpha Cognition Inc. has announced positive results from a bioequivalence study with Alpha-1062, a proprietary, delayed release oral tablet formulation in development for the treatment of mild to moderate Alzheimer’s disease.

An at-home, artificial intelligence-based system identified individuals with Parkinson’s disease and predicted disease severity and progression using nocturnal breathing signals, according to a study in Nature Medicine.

Gate Neurosciences is developing a new portfolio of next-generation therapeutics to treat synaptic dysfunction in patients with central nervous system disorders, the company announced in a press release.

Researchers at Aston University in England have received funding to explore new methods of recording electrical signals emitted from brain cells, which could lead to potential treatment for conditions like epilepsy and schizophrenia.

In this edition, leisure activities may lower risk for Alzheimer's disease and dementia; most common long COVID symptoms include fatigue and headache; ‘life-changing’ app-based digital therapeutic for tinnitus and more.

The FDA has granted premarket approval for Abbott’s Proclaim Plus spinal cord stimulation system, which can treat chronic pain across up to six areas of the body and is programmable to adjust to a person’s needs, the company announced in a release.

Being overweight was negatively associated with the incidence of dementia in women in Germany, while being underweight was linked to dementia in men, researchers reported in the Journal of Alzheimer’s Disease.